P

Proof Diagnostics, Inc.

16 employees

Proof Diagnostics develops CRISPR‑based COVID‑19 molecular tests to help communities take control of their health.

Basic info

Industry

medical equipment manufacturing

Sectors

CRISPR
Biotechnology
Product Management
Personal Health
Diagnostics
Molecular Biology
Wellness
Bioscience
Research
Apps
COVID-19
RT-LAMP
Health Care
Molecular Diagnostics
Healthcare
Mobile Apps
Point of Care Clinics
Lab Testing

Date founded

2020

Funding rounds raised

Total raised

$45M

from 4 investors over 4 rounds

P

Proof Diagnostics, Inc. raised $45M on April 7, 2022

Investors: F-Prime Capital Partners, Madrona Venture Group and ARCH Venture Partners

P

Proof Diagnostics, Inc. raised undisclosed on October 1, 2020

Investors: SV Angel

FAQ